General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
FOR IMMEDIATE RELEASE September 7, 2000 |
CONTACT: |
703 294 6008 or [email protected] |
The current survey found no evidence of such phasing out. It reports that only 22.1 percent of 1999 research grants were related to the most severe disorders and that only 8.3 percent were directed toward clinical or treatment aspects of these illnesses. The report compares the number of NIMH research grants for schizophrenia, manic-depressive illness, severe depression, and other severe mental disorders with the number of NIMH grants studying pigeons, songbirds, fish, and crickets. It also criticizes NIMH for allocating research resources to human and social problems that should be assigned to other government agencies instead of focusing on its primary mission. As the report notes: "Breast cancer, cognitive process of birds, alertness of railway engineers, reading problems, students transition to middle school, adolescent romantic relationships, daytime sleepiness, how emotion is perceived in musicthere are virtually no boundaries to what NIMH is currently funding."
The report criticizes NIMHs failure to do research on severe mental illnesses on economic grounds as well. A recent survey reported that severe mental illnesses account for 70 percent of the treatment costs for all mental illnesses and are responsible for 72 percent of all suicides. Federal expenditures for the cost of treatment and support of severe mental illnesses are one of the fastest growing items in the federal budget.
The lead author on the report, Dr. E. Fuller Torrey, who also is president of the Center, commented: "The most disturbing finding in the study was not NIMHs failure to do sufficient research on severe mental disorders. Rather, it was NIMHs grandiosity it seems to believe it should be doing research on virtually every human and social problem."
The Centers Executive Director Mary Zdanowicz, and a co-author of the report, said, "Research into new treatments that offer recovery and possible cures represents a ray of hope for millions of Americans stricken with the devastating effects of severe mental illness and their families. NIMH must restore this hope by returning to its central mission of reducing the burden of mental illness through research."
The authors of the report encourage everyone to log onto the NIH website (www.nih.gov), click on "Funding" and "CRISP database," and examine for themselves the summaries of NIMH-funded research grants.
The report makes five recommendations for improving the NIMH research portfolio, including:
To view the full report online, visit www.treatmentadvocacycenter.org/nimhreport/index.htm.
###
The Treatment Advocacy Center (www.treatmentadvocacycenter.org) is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment of severe mental illnesses. TAC promotes laws, policies, and practices for the delivery of psychiatric care and supports the development of innovative treatments for and research into the causes of severe and persistent psychiatric illnesses, such as schizophrenia and bipolar disorder.
general
resources | legal resources | medical
resources | briefing papers | state activity The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products.
hospital closures | preventable
tragedies | press room | search
| home
703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website)
[email protected] (general email) | [email protected] (press contact)
[email protected] (webmaster)